Refocusing generalized myasthenia gravis: Patient burden, disease profiles, and the role of evolving therapy

Background and purpose Generalized myasthenia gravis (gMG) continues to present significant challenges for clinical management due to an unpredictable disease course, frequent disease fluctuations, and varying response to therapy. The recent availability of new pharmacologic therapies presents a val...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	European journal of neurology Ročník 31; číslo 6; s. e16180 - n/a
Hlavní autoři:	Saccà, Francesco, Salort‐Campana, Emmanuelle, Jacob, Saiju, Cortés‐Vicente, Elena, Schneider‐Gold, Christiane
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	England John Wiley & Sons, Inc 01.06.2024
Témata:	Algorithms Availability Biomarkers classification Cost of Illness Decision making disease burden generalized myasthenia gravis Health services Human motion Humans Immune system Immunosuppressive agents Myasthenia gravis Myasthenia Gravis - drug therapy Myasthenia Gravis - therapy Neuromuscular junctions pathophysiology Patients Quality of Life Social impact targeted therapy targeted therapy disease burden classification generalized myasthenia gravis pathophysiology
ISSN:	1351-5101, 1468-1331, 1468-1331
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!